{
    "article_id": "PMC8462593",
    "article_text_type": "abstract",
    "article_filtered_sentences": [
        "Abstract - RESULTS\nProgression-free survival, the primary end point, was improved with the addition of vemurafenib (hazard ratio, 0.50,  \n         P = .001)."
    ],
    "registry_id": "NCT02164916",
    "registry_primary_outcomes": [
        "PFS (Arms I and II) , From date of Step 2 Randomization to date of first documentation of progression or symptomatic deterioration, or death due to any cause, assessed up to 3 years",
        "PFS (Crossover) , From date of Step 3 Crossover Registration to date of first documentation of progression or symptomatic deterioration, or death due to any cause, assessed up to 3 years"
    ],
    "labels": {
        "POS_identif_possible": "Yes",
        "PO_switch": "Yes",
        "PO_not_reported_registry": "No",
        "PO_not_reported_publication": "Yes",
        "POS_timeframe_metric": "No",
        "Description": ""
    },
    "article_bio_outcomes": [
        {
            "sentence_nb": 0,
            "tokens": [
                "Abstract",
                "-",
                "RESULTS",
                "Progression-free",
                "survival",
                ",",
                "the",
                "primary",
                "end",
                "point",
                ",",
                "was",
                "improved",
                "with",
                "the",
                "addition",
                "of",
                "vemurafenib",
                "(",
                "hazard",
                "ratio",
                ",",
                "0.50",
                ",",
                "P",
                "=",
                ".001",
                ")",
                "."
            ],
            "labels": [
                "O",
                "O",
                "O",
                "B-PrimaryOutcome",
                "I-PrimaryOutcome",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O"
            ]
        }
    ],
    "article_outcomes_text": [
        "Progression-free survival"
    ],
    "article2registry_connections": [
        {
            "article_index": 0,
            "registry_index": 0,
            "similar": true
        },
        {
            "article_index": 0,
            "registry_index": 1,
            "similar": true
        }
    ]
}